Ceribell

CBLL · NASDAQ

$27.68+$1.68 (+6.46%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $26.00

Latest news

Press releaseSep 30, 7:00 AM ETGlobe Newswire
Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis
Press releaseAug 10, 4:05 PM ETGlobe Newswire
Ceribell Reports Second Quarter 2026 Financial Results
Press releaseAug 10, 7:00 AM ETGlobe Newswire
Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review
Press releaseAug 3, 7:00 AM ETGlobe Newswire
Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System
Press releaseJul 29, 7:00 AM ETGlobe Newswire
Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe
Press releaseJun 8, 7:00 AM ETGlobe Newswire
Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes
Press releaseMay 11, 4:05 PM ETGlobe Newswire
Ceribell Reports First Quarter 2026 Financial Results
NewsMay 11, 7:11 AM ET
Earnings Scheduled For May 11, 2026
Press releaseFeb 24, 4:05 PM ETGlobe Newswire
Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results
NewsFeb 24, 6:11 AM ET
Earnings Scheduled For February 24, 2026
NewsFeb 23, 2:01 PM ET
CeriBell's Earnings: A Preview
NewsJan 28, 9:00 AM ET
Forecasting The Future: 5 Analyst Projections For CeriBell
Press releaseJan 16, 11:40 AM ETGlobe Newswire
AI Diagnostics: The End of the High-Cost Imaging Era
Press releaseJan 5, 8:00 AM ETGlobe Newswire
Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution
Press releaseDec 12, 9:49 AM ETPRNewswire
AI Diagnostics Hit Critical Mass as Hospitals Race to Cut Costs
NewsDec 9, 12:00 PM ETAvi Kapoor
Academy Sports and Outdoors, Tronox, STAAR Surgical And Other Big Stocks Moving Higher On Tuesday
Press releaseDec 9, 9:25 AM ETGlobe Newswire
Global AI Infrastructure Shift Ignites Biotech Growth Phase
Press releaseNov 4, 4:05 PM ETGlobe Newswire
Ceribell Reports Third Quarter 2025 Financial Results
NewsNov 4, 6:12 AM ET
Earnings Scheduled For November 4, 2025
NewsAug 5, 4:32 AM ET
Earnings Scheduled For August 5, 2025
Press releaseJun 20, 9:11 AM ETPRNewswire
AI Tools That Talk, Scan, and Save Lives Are Reshaping the Investment Landscape
NewsMay 8, 4:33 AM ET
Earnings Scheduled For May 8, 2025
NewsApr 11, 10:28 AM ETAvi Kapoor
Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday
Press releaseOct 29, 4:05 PM ETPRNewswire
Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024
Press releaseOct 16, 4:05 PM ETPRNewswire
New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG
Press releaseOct 15, 5:00 PM ETPRNewswire
CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
Press releaseOct 10, 11:27 PM ETPRNewswire
CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis

Ceribell Reports Second Quarter 2026 Financial Results

Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review

Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System

Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe

Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes

Ceribell Reports First Quarter 2026 Financial Results

Earnings Scheduled For May 11, 2026

Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results

Earnings Scheduled For February 24, 2026

CeriBell's Earnings: A Preview

Forecasting The Future: 5 Analyst Projections For CeriBell

AI Diagnostics: The End of the High-Cost Imaging Era

Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution

AI Diagnostics Hit Critical Mass as Hospitals Race to Cut Costs

Academy Sports and Outdoors, Tronox, STAAR Surgical And Other Big Stocks Moving Higher On Tuesday

Global AI Infrastructure Shift Ignites Biotech Growth Phase

Ceribell Reports Third Quarter 2025 Financial Results

Earnings Scheduled For November 4, 2025

Earnings Scheduled For August 5, 2025

AI Tools That Talk, Scan, and Save Lives Are Reshaping the Investment Landscape

Earnings Scheduled For May 8, 2025

Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday

Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024

New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG

CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering